Jason Gerberry
Analyst, Bank of America Securities
Replay available
Cara Therapeutics, Inc. (CARA) Q2 2023 Earnings Call
Cara Therapeutics, Inc. (NASDAQ: CARA) Q2 2023 earnings conference call, held 2023-08-07. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Sumant Karkarni
Analyst, Canaccord Genuity
Annabel Samini
Analyst, Stiefel
Matt Murphy
Investor Relations
Scott Derillian
General Counsel and Head of Government Affairs
Chris Posner
Chief Executive Officer
Ryan Maynard
Chief Financial Officer
David Amselem
Analyst, Piper Sandler
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Tvardi Therapeutics, Inc..
Replay transcript excerpt
WEBVTT 00:00:00.049 -- 00:00:05.170 to Cara Therapeutic's second quarter 2023 earnings call. 00:00:05.170 -- 00:00:08.951 At this time, all participants are in a listen-only mode. 00:00:08.951 -- 00:00:13.212 After the speaker presentation, there will be a question and answer session. 00:00:13.212 -- 00:00:18.673 To ask a question during the session, you will need to press star 1 1 on your telephone. 00:00:18.673 -- 00:00:22.494 To remove yourself from the queue, please press star 1 1 again. 00:00:22.494 -- 00:00:26.955 I would now like to hand the call over to Matt Murphy, Investor Relations. 00:00:26.955 -- 00:00:29.675 Please go ahead. 00:00:30.049 -- 00:00:34.952 Thank you, operator, and good afternoon. After market closed today, CARA issued a news 00:00:34.952 -- 00:00:39.274 release announcing the company's financial and operating results for the second quarter 00:00:39.274 -- 00:00:41.284 of 2023. 00:00:41.315 -- 00:00:46.018 Copies of this news release and the associated SEC filing can be found in the investor 00:00:46.018 -- 00:00:49.798 section of our website at www.caratherapeutics.com. 00:00:50.980 -- 00:00:54.895 Before we begin, let me remind you that during the course of this conference call, we 00:00:54.895 -- 00:00:59.297 will be making certain forward-looking statements about CARA and our programs based on 00:00:59.297 -- 00:01:02.259 management's current plans and expectations. 00:01:02.259 -- 00:01:06.311 These statements are being made under the Private Securities Litigation Reform Act of 00:01:06.311 -- 00:01:07.981 1995 00:01:07.981 -- 00:01:11.123 and are subject to risks and uncertainties. 00:01:11.123 -- 00:01:16.345 Actual results may differ materially due to various factors, and CARA undertakes 00:01:16.345 -- 00:01:21.788 no obligation to...